An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

Completed · Not applicable

Conditions studied: Ocular Hypertension

In brief

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Key facts

Study ID

NCT00825396

Run by

Chakshu Research, Inc.

People needed

12

Starts

2007-04-01

Expected to finish

2009-04-01

Last updated by the study team

2009-06-11

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
• Both eyes having best corrected visual acuity better than 20/50

You may not qualify if…

• Advanced glaucoma
• Closed or barely open anterior chamber or history of angle closure

Where it is running

• Charlotte Eye, Ear, Nose & Throat Associates — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.